Freestone Capital Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,020
| Closed | -$93.5K | – | 468 |
|
|
2024
Q3 | $93.5K | Buy |
+18,020
| New | +$93.5K | ﹤0.01% | 417 |
|
|
2024
Q2 | – | Sell |
-18,020
| Closed | -$88.7K | – | 478 |
|
|
2024
Q1 | $88.7K | Hold |
18,020
| – | – | ﹤0.01% | 427 |
|
|
2023
Q4 | $158K | Hold |
18,020
| – | – | 0.01% | 377 |
|
|
2023
Q3 | $207K | Hold |
18,020
| – | – | 0.01% | 335 |
|
|
2023
Q2 | $456K | Hold |
18,020
| – | – | 0.02% | 260 |
|
|
2023
Q1 | $580K | Hold |
18,020
| – | – | 0.03% | 237 |
|
|
2022
Q4 | $333K | Sell |
18,020
-12,236
| -40% | -$226K | 0.02% | 280 |
|
|
2022
Q3 | $817K | Hold |
30,256
| – | – | 0.04% | 215 |
|
|
2022
Q2 | $418K | Buy |
30,256
+599
| +2% | +$8.28K | 0.02% | 285 |
|
|
2022
Q1 | $578K | Hold |
29,657
| – | – | 0.02% | 319 |
|
|
2021
Q4 | $484K | Buy |
29,657
+383
| +1% | +$6.25K | 0.02% | 322 |
|
|
2021
Q3 | $816K | Hold |
29,274
| – | – | 0.04% | 234 |
|
|
2021
Q2 | $868K | Hold |
29,274
| – | – | 0.04% | 225 |
|
|
2021
Q1 | $818K | Hold |
29,274
| – | – | 0.04% | 223 |
|
|
2020
Q4 | $830K | Buy |
+29,274
| New | +$830K | 0.05% | 205 |
|